LAUREN LEWIS: Open Payments
NPI 1497379408 · RAVENNA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 51 payments from 19 companies in 2025. Trend: 2023 $795 · 2024 $819 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $176 |
| GlaxoSmithKline, LLC. | 17 | $163 |
| Verona Pharma, Inc. | 4 | $100 |
| GENZYME CORPORATION | 3 | $88 |
| Merck Sharp & Dohme LLC | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: FASENRA, NUCALA, DUPIXENT, Ohtuvayre, WINREVAIR, Adempas, TEZSPIRE, OPSUMIT.
Industry payments across OH — which companies pay providers there.
